Ckd Bio (063160) — Capital Reinvestment Ratio
Latest as of June 2026:
1.29x
Ckd Bio (063160) has a Capital Reinvestment Ratio of 1.29x as of June 2026, meaning it reinvests 1% of its operating cash flow (₩2.62 Billion) in capital expenditures (₩3.37 Billion). Check Ckd Bio tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
1.29x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.62 Billion
KRW
Capital Expenditures
₩3.37 Billion
KRW
Data as of
Jun 2026
Most recent filing
Ckd Bio Capital Reinvestment Ratio (2008–2024)
This chart tracks Ckd Bio's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ckd Bio.
Annual Capital Reinvestment Ratio for Ckd Bio (2008–2024)
Year-by-year Capital Reinvestment Ratio for Ckd Bio from 2008 to 2024. See cash generation quality of Ckd Bio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.31x | ₩14.03 Billion | ₩4.28 Billion | ▼ -97.6% |
| 2020 | 12.78x | ₩4.82 Billion | ₩61.66 Billion | ▲ +359.0% |
| 2019 | 2.78x | ₩16.99 Billion | ₩47.31 Billion | ▲ +163.9% |
| 2018 | 1.06x | ₩15.54 Billion | ₩16.40 Billion | ▲ +123.1% |
| 2017 | 0.47x | ₩20.45 Billion | ₩9.67 Billion | ▼ -31.8% |
| 2016 | 0.69x | ₩15.50 Billion | ₩10.76 Billion | ▼ -16.5% |
| 2015 | 0.83x | ₩14.34 Billion | ₩11.91 Billion | ▲ +225.1% |
| 2014 | 0.26x | ₩11.22 Billion | ₩2.87 Billion | ▼ -31.9% |
| 2013 | 0.38x | ₩10.92 Billion | ₩4.10 Billion | ▲ +56.7% |
| 2012 | 0.24x | ₩22.90 Billion | ₩5.48 Billion | ▼ -86.0% |
| 2011 | 1.70x | ₩12.96 Billion | ₩22.09 Billion | ▲ +106.2% |
| 2010 | 0.83x | ₩23.89 Billion | ₩19.74 Billion | ▲ +62.3% |
| 2009 | 0.51x | ₩26.57 Billion | ₩13.53 Billion | ▲ +56.8% |
| 2008 | 0.32x | ₩10.69 Billion | ₩3.47 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow